New Insights in the Treatment of Severe Infections in the Multiple-Drug Resistant Situation (Highlights of the Daiichi Pharmaceutical Co., Ltd. Satellite Symposium to the 11th International Congress on Infectious Diseases)
 |
|
| Introduction | |
|
|
| Comparative Antimicrobial Susceptibility of Respiratory Tract Pathogens | |
 |
David Felmingham, BSc MSc Dip LSHTM Chief Executive , GR Micro Ltd, London, UK Honorary Senior Lecturer London School of Hygiene and Tropical Medicine London, UK |
|
|
| Experience with Levofloxacin in a Critical Pathwey for the Treatment of Community-Acquired Pneumonia | |
 |
Thomas J. Marrie, MD Professor and Chair, Department of Medicine University of Alberta, Edmonton, AB, Canada |
|
|
| Clinical Applications of Levofloxacin in Severe Infections | |
 |
Wolfgang Graninger, MD PhD Professor of Medicine Head, Division of Infectious Diseases and Chemotherapy Internal Medicine University of Vienna, Vienna, Austria |
|
|
| New Insights in the Treatment by Levofloxacin | |
 |
Thomas M. File, Jr, MD MS, Chair Chief, Infectious Disease Service Summa Health System, Akron, OH, USA Professor of Internal Medicine Northeastern Ohio Universities College of Medicine Rootstown, OH, USA |
|
|
LATEST TOPICS
RELATED ARTICLES
